Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05370287 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adaptive Optics Retinal Imaging

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 80 to 150
    • Primary and study completion dates: Sep 30, 2026 to Sep 30, 2028
    • Eligibility criteria expanded, about 19 words
    • Study description expanded, about 1 word
    v4
  2. 2 versions Re-verified since Dec 22, 2023, no change to tracked fieldsv2-v3
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to collect and assess adaptive optics (AO) retinal images from human subjects in support of projects to demonstrate, advance, and enhance clinical use of AO technology.
Trial Details
NCT Number NCT05370287
Lead Sponsor Food and Drug Administration (FDA)
Collaborators: University of Maryland, Baltimore
Conditions
(from sponsor)		 Glaucoma, Primary Open Angle
Related terms Glaucoma, Open-Angle
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov